These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12219749)

  • 1. Immune tolerance and stroke: a turning point.
    Feuerstein N; Goldman S; Feuerstein G
    Stroke; 2002 Sep; 33(9):2163-4. PubMed ID: 12219749
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats.
    Takeda H; Spatz M; Ruetzler C; McCarron R; Becker K; Hallenbeck J
    Stroke; 2002 Sep; 33(9):2156-63. PubMed ID: 12215580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mucosal tolerance to E-selectin targets immunomodulation to activating vessel segments and prevents ischemic and hemorrhagic stroke.
    Takeda H; Spatz M; Ruetzler C; McCarron R; Becker K; Hallenbeck J
    Ernst Schering Res Found Workshop; 2004; (47):117-32. PubMed ID: 15032057
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats.
    Ishibashi S; Maric D; Mou Y; Ohtani R; Ruetzler C; Hallenbeck JM
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):606-20. PubMed ID: 19107136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalant induces tolerance against stroke.
    Sutherland S
    Drug Discov Today; 2002 Nov; 7(22):1112-3. PubMed ID: 12546847
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucosal tolerance to E-selectin and response to systemic inflammation.
    Illoh K; Campbell C; Illoh O; Diehl J; Cherry J; Elkhaloun A; Chen Y; Hallenbeck J
    J Cereb Blood Flow Metab; 2006 Dec; 26(12):1538-50. PubMed ID: 16596122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation by inducing tolerance to E-selectin and adult neurogenesis after stroke].
    Ishibashi S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):882-5. PubMed ID: 21921488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury.
    Chen Y; Ruetzler C; Pandipati S; Spatz M; McCarron RM; Becker K; Hallenbeck JM
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15107-12. PubMed ID: 14645708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal tolerance to E-selectin provides protection against cerebral ischemia-reperfusion injury in rats.
    Yun W; Qing-Cheng L; Lei Y; Jia-Yin M
    J Neuroimmunol; 2008 Dec; 205(1-2):73-9. PubMed ID: 18937981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-dependent effect of nasal instillation of antigen on the immune response in mice.
    Melo ME; Gabaglia CR; Moudgil KD; Sercarz EE; Quinn A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):902-7. PubMed ID: 12455176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential affection of intestinal immune cell populations after cerebral ischemia in mice.
    Schulte-Herbrüggen O; Quarcoo D; Meisel A; Meisel C
    Neuroimmunomodulation; 2009; 16(3):213-8. PubMed ID: 19246945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
    Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
    Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal antigen presentation and the control of tolerance and immunity.
    Nagler-Anderson C; Terhoust C; Bhan AK; Podolsky DK
    Trends Immunol; 2001 Mar; 22(3):120-2. PubMed ID: 11334024
    [No Abstract]   [Full Text] [Related]  

  • 14. Early events in antigen-specific regulatory T cell induction via nasal and oral mucosa.
    Samsom JN; Hauet-Broere F; Unger WW; VAN Berkel LA; Kraal G
    Ann N Y Acad Sci; 2004 Dec; 1029():385-9. PubMed ID: 15681788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Cerebral Small Vessel Disease.
    Smith EE
    Semin Neurol; 2017 Jun; 37(3):316-325. PubMed ID: 28759913
    [No Abstract]   [Full Text] [Related]  

  • 16. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance in humans: T cell but not B cell tolerance to a soluble protein antigen.
    Husby S; Mestecky J; Moldoveanu Z; Elson CO
    Adv Exp Med Biol; 1995; 371B():1225-8. PubMed ID: 7502788
    [No Abstract]   [Full Text] [Related]  

  • 18. About stroke and pediatric stroke.
    Woo D
    Neurology; 2015 Oct; 85(17):e135. PubMed ID: 26811854
    [No Abstract]   [Full Text] [Related]  

  • 19. An emerging role of mast cells in cerebral ischemia and hemorrhage.
    Strbian D; Kovanen PT; Karjalainen-Lindsberg ML; Tatlisumak T; Lindsberg PJ
    Ann Med; 2009; 41(6):438-50. PubMed ID: 19412821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses after acute ischemic stroke or myocardial infarction.
    Haeusler KG; Schmidt WU; Foehring F; Meisel C; Guenther C; Brunecker P; Kunze C; Helms T; Dirnagl U; Volk HD; Villringer A
    Int J Cardiol; 2012 Mar; 155(3):372-7. PubMed ID: 21078527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.